HOYA ConBio™ Announces Availability of PurpuraLite™, a Revolution in Purpura-Laser Treatments
Fremont, CA, January 2007 – HOYA ConBio™, a leading provider of laser solutions for medical and dental practices worldwide, announced today that its new chromophore-clearing device, the PurpuraLite™, can be used to minimize or eliminate purpura that typically results from certain aesthetic laser treatments.
Purpura is the purplish discoloration in the skin, resulting from minor bleeding within the skin that often appears following laser treatment. PurpuraLite™ allows the physician to temporarily “empty” the fine blood vessels under the treatment area, eliminating the “red” chromophore that would typically absorb energy and create a purpuric response. By moving the red blood cells out of the way, red blood cells are not disrupted and purpura is avoided.
“ PurpuraLite™ exemplifies our ongoing commitment to establishing our MedLite™ laser as the first and only system versatile enough for all aesthetic applications and skin types,” said Timothy Gehlmann, President & CEO of HOYA ConBio.
“The MedLite™ line of lasers has over 15 years of consistent reliability, safety and unparallel return on investment,” notes the Aesthetic Buyers Guide, March/April 2006. (www.miinews.com)“With the fastest treatment periods available, MedLite™ lasers’ dollar per minute (DPM) return is unmatched.”
PurpuraLite™ is now shipped as a standard accessory with all MedLite™ lasers, and can be purchased as an option to lasers already in use throughout the world.
A U.S.-based laser manufacturer, HOYA ConBio™ designs, manufactures and markets sophisticated laser systems used in aesthetic, medical and dental practices worldwide. The company’s innovative technologies are highly versatile, effective, and offer rapid return on investment.
The company’s MedLite™ Q-switched Nd: YAG laser series is used in high-demand aesthetic laser procedures including facial skin toning and rejuvenation, and the treatment of wrinkles, spider veins, scars and acne, and the reduction of hair, tattoos and age spots. The company markets its MedLite™ laser series to dermatologists, plastic surgeons, family and ob-gyn practices, and medical spas worldwide.
HOYA ConBio™ designs, manufactures and markets two separate laser systems to the global dental community: the VersaWave™ Er: YAG All-Tissue Laser and the DioDent™ Soft Tissue Diode Laser series. The company’s VersaWave™ is used in dental applications for aesthetic tissue recontouring, frenectomies, direct preparations and closed flap bone recontouring. The VersaWave™ features high repetition rates, high power output, and exceptional delivery ergonomics. The DioDent™ II series provides a cost-effective way for dentists to bring the newest generation of diode laser technology to their practices and is ideal for hygiene maintenance programs, soft tissue and aesthetic dental procedures. Both the VersaWave™ and the DioDent™ II offer operational versatility and portability.
Headquartered in Fremont, CA, HOYA ConBio™ has offices in Europe and Japan and maintains a worldwide product and service distribution network. HOYA ConBio™ is based at 47733 Fremont Boulevard, Fremont, CA 94538. Tel., 800-532-1064 and 510-445-4500; Fax, 510-445-4550; Email: info@conbio.com. HOYA ConBio™ is a subsidiary of HOYA Corporation, a leader in optical solutions for information technology, vision care and photonics.